InvestSMART

Singular Health Group Ltd (ASX: SHG) - Share Price

Current share price for SHG : $0.180 0.005 (2.86%)+

Singular Health Group Limited (SHG), an ASX-listed company, is a Company that is engaged in Negotiation and Execution of MoU with Provider Network Solutions (PNS); Technical Development of 3Dicom Software; Corporate Activities and Investor Relations; Quality and Regulatory and Disposal of 3DP assets.

SHG General Information +

ASX Code SHG
Website http://singular.health
Industry/Sector Health Care Technology
Market Cap ($M) 57
SHG Share Price $0.180
Day High $0.185
Day Low $0.170
Last Close $0.175
SHG Share Price Movement $0.01 ( 2.86% )
Prices as at 16:40, 26 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Singular Health Group Ltd (SHG) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Singular Health Group Ltd (SHG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Singular Health Group Ltd (SHG) price-sensitive announcements

SHG - Quarterly Activities/Appendix 4C Cash Flow Report
Singular Health Group Limited (ASX: SHG) reported strong progress in the quarter ending 31
Singular Health Group Ltd (SHG)
28 Apr 2026 | 8:24 AM
SHG - Key Milestone Achieved with PNS - USD$500,000 received
Singular Health Group Ltd, under a binding enterprise agreement, has received USD$500,000
Singular Health Group Ltd (SHG)
22 Apr 2026 | 9:44 AM
SHG - Appendix 4D Half Yearly Report and Accounts
Singular Health Group Ltd's half-year financial report for the period ending 31 December 2
Singular Health Group Ltd (SHG)
24 Feb 2026 | 8:12 AM
SHG - Quarterly Activities/Appendix 4C Cash Flow Report
Singular Health Group Ltd made significant progress in the December quarter by advancing k
Singular Health Group Ltd (SHG)
27 Jan 2026 | 9:01 AM

Singular Health Group Ltd (SHG) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Appendix 3Y - Change of Director's Interest Notice 24 Jun 2026 11:54AM $0.190 $0.180 fallen by 5.26%
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Option Exercise and Cleansing Notice 23 Jun 2026 8:55AM $0.200 $0.180 fallen by 10%
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Application for quotation of securities - SHG 23 Jun 2026 8:54AM $0.200 $0.180 fallen by 10%
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Option Exercise and Cleansing Notice 14 May 2026 5:27PM $0.210 $0.180 fallen by 14.29%
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Application for quotation of securities - SHG 14 May 2026 5:23PM $0.210 $0.180 fallen by 14.29%
Singular Health Group Ltd (SHG)
ORDINARY FULLY PAID
 Health Care $58 Option Exercise and Cleansing Notice 1 May 2026 6:31PM $0.205 $0.180 fallen by 12.20%

SHG Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$6.26 -$2.60 46.70% 0.00 0.00 0.00% 0.0%
2024A -$2.88 -$1.80 -55.80% 0.00 0.00 0.00% 0.0%
2023A -$4.68 -$4.10 -30.10% 0.00 0.00 0.00% 0.0%

SHG Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
4DMedical Limited (4DX) $2,721M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $19,368M 0.3919 0.2545 0.2962 168.3833 134.2239 103.5525 0.30% 0.38% 0.50%
Singular Health Group Ltd (SHG) $56M 0.4667 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

SHG Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 4.15 0.00
Market 0.29 13.30 1.15 0.66
Sector 0.65 22.30 1.60 2.80

SHG Directors

Name Position Start Date
Mr Denning Sang-Tatt Chong Chief Executive Officer, Managing Director 20 Feb 2020
Mr Howard Andrew Digby Non-Executive Chairman, Non-Executive Director 27 Jan 2021
Mr Andrew Ian Just Non-Executive Director 27 Jan 2021

Singular Health Group Ltd (SHG) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Jun 2026 CHONG, Denning Exercise Options 1,818,182 $0.100 $181,818.200
22 Jun 2026 CHONG, Denning Buy Indirect Shares 1,818,182 $0.100 $181,818.200
18 Mar 2026 DIGBY, Howard Buy Direct Shares 41,666 $0.240 $10,000.000

See all changes in directors' interest & trades for Singular Health Group Ltd (SHG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SHG Management

Name Position
Kyla Garic Chief Financial Officer
Martina Mariano Chief Operating officer
Steven Douglas Wood Company Secretary

SHG Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Singular Health Group Ltd (SHG). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
20,618,407 (6.77%) Marin and Sons Strategies LLC
15,611,537 (5.13%) Denning Sang-Tatt Chong

SHG Calendar of Events

Date Event
23 February 2027 Report (Interim)
28 August 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.